CybeRelease: (OTC: MTNA) Begins Trading On Frankfurt Exchange
(CybeRelease, May 25, 2006) - Lake Harmony, PA - Material Technologies, Inc. (OTC BB: MTNA) (“MATECH”) announced that it has begun trading on the Frankfurt Stock Exchange, the world’s third largest securities exchange. Listing on the exchange enables MATECH to communicate its value and growth to the international investment community and gain access to global capital markets.
MATECH is trading under symbol “UAW” (Frankfurt: UAW.F). Its International Security Identification Number (ISIN/CUSIP) is US5766782057 and German Security Code is AOCABD.
MATECH CEO Robert M. Bernstein commented: “MATECH has developed revolutionary metal fatigue detection technology that can accurately measure the integrity of critical structures including bridges and railroads. Our patented Electrochemical Fatigue Sensor (EFS(TM)) is the only nondestructive testing device able to find growing cracks as small as 0.010 inches. The Frankfurt Stock Exchange enables us to communicate MATECH’s unique value to a wider pool of investors and invite them to share in our company’s growth.”
The Frankfurt Stock Exchange is the world’s third largest trading center for securities and Germany’s largest exchange. It is responsible for 90 percent of the securities trading volume in Germany. The Exchange facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors. For more information, please visit http://deutsche-boerse.com
To read the complete release, go to http://www.CybeRelease.com/mtna52506.htm
For in-depth analyst coverage, go to http://www.smallcapstockwatch.com
CybeRelease Gainers are Tripos, Inc. (Nasdaq: TRPS), Firstwave Technologies Inc. (Nasdaq: FSTW), EDEN Bioscience Corporation (Nasdaq: EDEN), Sangamo BioSciences, Inc. (Nasdaq: SGMO), Carrington Laboratories, Inc. (Nasdaq: CARN), Capstone Turbine Corporation (Nasdaq: CPST), Threshold Pharmaceuticals, Inc. (Nasdaq: THLD) and Cerus Corporation (Nasdaq: CERS).
CybeRelease Decliners are Quality Distribution, Inc. (Nasdaq: QLTY), Nastech Pharmaceutical Company, Inc. (Nasdaq: NSTK), INTAC International (Nasdaq: INTN), Research Frontiers Incorporated (Nasdaq: REFR), XM Satellite Radio Holdings Inc. (Nasdaq: XMSR), Global ePoint, Inc. (Nasdaq: GEPT), Oralabs Holding Corp. (Nasdaq: OLAB) and Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $895.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.